Score Overview
Explore the 2021 public Archive ranking →
Where Amgen Inc has ranked, year by year
Showing 30 years ranking history by HDB Score.
Top 50 on HDB Score for 6 consecutive years, since 2016, through 2021.
- AMGN
2016: 5.6% · 2021: 3.1% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 418.13 | — |
1 Year2025-09-26 | $ 265.61 | 57.42% |
5 Years2021-09-28 | $ 181.68 | 130.14% |
10 Years2016-09-28 | $ 125.95 | 231.98% |
20 Years2006-09-28 | $ 47.76 | 8x |
30 Years1996-09-27 | $ 10.51 | 39x |
All Time1983-06-17 | $ 0.23 | 1821x |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | 30 Years1996-09-27 | All Time1983-06-17 |
|---|---|---|---|---|---|---|---|
| Price | $ 418.13 | $ 265.61 | $ 181.68 | $ 125.95 | $ 47.76 | $ 10.51 | $ 0.23 |
| Return | — | 57.42% | 130.14% | 231.98% | 8x | 39x | 1821x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 38.12B | $ 8.74B | $ 13.98B |
| 2025 | $ 36.74B | $ 7.71B | $ 9.12B |
| 2024 | $ 33.42B | $ 4.09B | $ 11.97B |
| 2023 | $ 28.19B | $ 6.71B | $ 10.94B |
| 2022 | $ 26.32B | $ 6.55B | $ 9.30B |
| 2021 | $ 25.97B | $ 5.89B | $ 8.03B |
| 2020 | $ 25.42B | $ 7.26B | $ 10.64B |
| 2019 | $ 23.36B | $ 7.84B | $ 8.91B |
| 2018 | $ 23.74B | $ 8.39B | $ 29.30B |
| 2017 | $ 22.84B | $ 1.97B | $ 41.67B |
| 2016 | $ 22.99B | $ 7.72B | $ 38.08B |
| 2015 | $ 21.66B | $ 6.93B | $ 31.38B |
| 2014 | $ 20.06B | $ 5.15B | $ 27.02B |
| 2013 | $ 18.67B | $ 5.08B | $ 19.40B |
| 2012 | $ 17.26B | $ 4.34B | $ 24.06B |
| 2011 | $ 15.58B | $ 3.68B | $ 20.64B |
| 2010 | $ 15.05B | $ 4.62B | $ 17.42B |
| 2009 | $ 14.64B | $ 4.60B | $ 13.44B |
| 2008 | $ 15.00B | $ 4.19B | $ 9.55B |
| 2007 | $ 14.77B | $ 3.16B | $ 7.15B |
| 2006 | $ 14.26B | $ 2.95B | $ 6.27B |
| 2005 | $ 12.43B | $ 3.67B | $ 5.25B |
| 2004 | $ 10.55B | $ 2.36B | $ 5.80B |
| 2003 | $ 8.35B | $ 2.25B | $ 5.12B |
| 2002 | $ 5.52B | -$ 1.39B | $ 4.66B |
| 2001 | $ 4.01B | $ 1.11B | $ 2.66B |
| 2000 | $ 3.44B | $ 1.13B | $ 2.02B |
| 1999 | $ 3.20B | $ 1.09B | $ 1.33B |
| 1998 | $ 2.64B | $ 863M | $ 201M |
| 1997 | $ 2.34B | $ 644M | $ 239M |
| 1996 | $ 2.19B | $ 679M | $ 169M |
| 1995 | $ 1.90B | $ 537M | $ 66M |
| 1994 | $ 1.62B | $ 319M | $ 211M |
| 1993 | $ 1.35B | $ 383M | $ 128M |
| 1992 | $ 1.08B | $ 357M | $ 92M |
| 1991 | $ 679M | $ 97M | $ 146M |
| 1990 | $ 190M | $ 19M | $ 35M |
| 1989 | $ 190M | $ 19M | $ 39M |
| 1988 | $ 70M | -$ 8M | $ 20M |
| 1987 | $ 44M | $ 1M | $ 105M |
| 1986 | $ 29M | $ 800K | $ 57M |
| 1985 | $ 21M | $ 500K | $ 66M |
Amgen Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 25.42B to $ 36.74B and net income grew from $ 7.26B to $ 7.71B. Revenue increased in every one of those 5 years; net income in 4.
Across Amgen Inc's full reported history, from 1985 to 2025, revenue grew from $ 21M to $ 36.74B and net income grew from $ 500K to $ 7.71B. Revenue increased in 90% of the years measured; net income in 68%.
Amgen Inc currently holds a 20-year HDB Score of 6.4 out of 10. How the HDB Score is calculated.
Membership
Continue AMGN’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
